TY - JOUR
T1 - Cdc42 is a key regulator of B cell differentiation and is required for antiviral humoral immunity
AU - Burbage, Marianne
AU - Keppler, Selina J
AU - Gasparrini, Francesca
AU - Martínez-Martín, Nuria
AU - Gaya, Mauro
AU - Feest, Christoph
AU - Domart, Marie-Charlotte
AU - Brakebusch, Cord Herbert
AU - Collinson, Lucy
AU - Bruckbauer, Andreas
AU - Batista, Facundo D
N1 - © 2015 Burbage et al.
PY - 2015/1/12
Y1 - 2015/1/12
N2 - The small Rho GTPase Cdc42, known to interact with Wiskott-Aldrich syndrome (WAS) protein, is an important regulator of actin remodeling. Here, we show that genetic ablation of Cdc42 exclusively in the B cell lineage is sufficient to render mice unable to mount antibody responses. Indeed Cdc42-deficient mice are incapable of forming germinal centers or generating plasma B cells upon either viral infection or immunization. Such severe immune deficiency is caused by multiple and profound B cell abnormalities, including early blocks during B cell development; impaired antigen-driven BCR signaling and actin remodeling; defective antigen presentation and in vivo interaction with T cells; and a severe B cell-intrinsic block in plasma cell differentiation. Thus, our study presents a new perspective on Cdc42 as key regulator of B cell physiology.
AB - The small Rho GTPase Cdc42, known to interact with Wiskott-Aldrich syndrome (WAS) protein, is an important regulator of actin remodeling. Here, we show that genetic ablation of Cdc42 exclusively in the B cell lineage is sufficient to render mice unable to mount antibody responses. Indeed Cdc42-deficient mice are incapable of forming germinal centers or generating plasma B cells upon either viral infection or immunization. Such severe immune deficiency is caused by multiple and profound B cell abnormalities, including early blocks during B cell development; impaired antigen-driven BCR signaling and actin remodeling; defective antigen presentation and in vivo interaction with T cells; and a severe B cell-intrinsic block in plasma cell differentiation. Thus, our study presents a new perspective on Cdc42 as key regulator of B cell physiology.
U2 - 10.1084/jem.20141143
DO - 10.1084/jem.20141143
M3 - Journal article
C2 - 25547673
SN - 0022-1007
VL - 212
SP - 53
EP - 72
JO - The Journal of Experimental Medicine
JF - The Journal of Experimental Medicine
IS - 1
ER -